SHOKLO MALARIA RESEARCH UNIT
🇹ðŸ‡Thailand
- Country
- 🇹ðŸ‡Thailand
- Ownership
- -
- Established
- 1986-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.shoklo-unit.com/
Vivax Elimination With Tafenoquine (VET) Study
Phase 4
Active, not recruiting
- Conditions
- Malaria, VivaxPlasmodium VivaxPlasmodium Vivax MalariaMalaria
- Interventions
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Shoklo Malaria Research Unit
- Target Recruit Count
- 1000
- Registration Number
- NCT06575647
- Locations
- 🇹ðŸ‡
Shoklo Malaria Research Unit (SMRU), Mae Sot, Tak Province, Thailand
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Phase 4
Recruiting
- Conditions
- Malaria, VivaxMalariaPlasmodium Vivax Malaria
- Interventions
- Drug: Artemether-Lumefantrine plus Tafenoquine (450 mg adult dose)Drug: Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Shoklo Malaria Research Unit
- Target Recruit Count
- 606
- Registration Number
- NCT05788094
- Locations
- 🇹ðŸ‡
Shoklo Malaria Research Unit (SMRU), Mae Sot, Tak, Thailand
© Copyright 2025. All Rights Reserved by MedPath